Adaptive Biotechnologies Corp Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Adaptive Biotechnologies Corp quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • Adaptive Biotechnologies Corp Costs and Expenses for the quarter ending September 30, 2024 was $79.1M, a 11% decline year-over-year.
  • Adaptive Biotechnologies Corp Costs and Expenses for the twelve months ending September 30, 2024 was $377M, a 0.59% increase year-over-year.
  • Adaptive Biotechnologies Corp annual Costs and Expenses for 2023 was $397M, a 3.07% increase from 2022.
  • Adaptive Biotechnologies Corp annual Costs and Expenses for 2022 was $385M, a 6.11% increase from 2021.
  • Adaptive Biotechnologies Corp annual Costs and Expenses for 2021 was $363M, a 44.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $397M +$11.8M +3.07% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $385M +$22.2M +6.11% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $363M +$112M +44.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $251M +$87.7M +53.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 $163M +$58M +55.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $105M +$22.5M +27.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $82.9M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.